Product Program year 2025 Source: CMS Open Payments

Gamunex-C

Biological Immunology and Neurology

NDC 13533-800-24

Open in the dashboard

General payments

$2,095,465

20,995 payments

Research payments

$5,553,357

291 payments

Through program year 2025, $2,095,465 in general payments and $5,553,357 in research payments were reported against Gamunex-C (Immunology and Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

13 rows
Year Kind Amount Payments
2025 General $363,712 4,127
2024 General $441,216 3,713
2024 Research $27,465 1
2023 General $402,177 3,478
2023 Research $165,829 25
2022 General $269,119 2,466
2022 Research $479,698 60
2021 General $173,227 1,487
2021 Research $1,625,464 91
2020 General $184,379 1,504
2020 Research $2,880,366 74
2019 General $261,634 4,220
2019 Research $374,535 40

Breakdown

Who paid General payments · program years 2019–2025
  1. Grifols USA, LLC $1,900,122 20,708 payments
  2. Grifols Shared Services North America, Inc. $180,843 282 payments
  3. Grifols, S.A. $13,100 4 payments
  4. Grifols Therapeutics LLC $1,400 1 payment
Top recipients General payments · program year 2025
  1. Suraj Muley Neurology · Phoenix, AZ $43,723 12% · 38 payments
  2. Gil Wolfe Neurology · Buffalo, NY $25,976 7% · 22 payments
  3. John England Neurology · New Orleans, LA $18,586 5% · 31 payments
  4. Samir MacWan Neuromuscular Medicine · Rancho Mirage, CA $15,620 4% · 15 payments
  5. Rossitza Chichkova Neurology · Tampa, FL $15,068 4% · 28 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Neurology Psychiatry & Neurology $251,858 79% · 980 practitioners
  2. Neuromuscular Medicine Psychiatry & Neurology $22,512 7% · 21 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $13,254 4% · 286 practitioners
  4. Physician Assistant $6,074 2% · 140 practitioners
  5. Nurse Practitioner $4,915 2% · 109 practitioners

The top 5 of 77 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $83,241 23% · 191 recipients
  2. Arizona $74,699 21% · 53 recipients
  3. New York $46,145 13% · 201 recipients
  4. Louisiana $24,421 7% · 58 recipients
  5. Florida $24,027 7% · 169 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

56,913

Prescriptions dispensed, refills included

Drug cost

$459,436,647

Paid at the pharmacy, in all

Prescribers

1,802

With 11 or more claims of it

Medicare Part D drugs matched to Gamunex-C, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Gamunex-C Immune Globul G/Gly/Iga Avg 46 Same name 1,802 56,913 $459,436,647

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Abigail Stocker Gastroenterology KY 643 $8,981,381 None on record
Mohamed Khalil Neurology TX 361 $2,845,740 $137
Danielle O'Brien Nurse Practitioner FL 342 $4,130,348 None on record
Guy Burrows Neurology TX 341 $3,760,015 $337
Samir MacWan Neurology CA 325 $2,570,321 $17,492

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Given in the clinic

Part B · billing code
Medicare Part B billing codes matched to Gamunex-C
Billing code Providers Services Paid by Medicare
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg J1561 206 1,819,367 $69,731,751

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

20,995 general · 291 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record